10/23
08:18 am
xoma
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $117.00 price target on the stock.
Low
Report
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $117.00 price target on the stock.
10/22
08:00 am
xoma
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
Low
Report
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
9/23
06:30 am
xoma
Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
Low
Report
Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
9/23
05:30 am
xoma
XOMA Royalty Declares Quarterly Preferred Stock Dividends
Low
Report
XOMA Royalty Declares Quarterly Preferred Stock Dividends
9/20
01:29 pm
xoma
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $117.00 price target on the stock.
Medium
Report
XOMA Co. (NASDAQ: XOMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $117.00 price target on the stock.
9/4
07:30 am
xoma
XOMA Royalty to Present at Upcoming Investor Conferences in September
Medium
Report
XOMA Royalty to Present at Upcoming Investor Conferences in September
8/15
08:35 am
xoma
XOMA Co. (NASDAQ: XOMA) had its price target raised by analysts at HC Wainwright from $74.00 to $117.00. They now have a "buy" rating on the stock.
Medium
Report
XOMA Co. (NASDAQ: XOMA) had its price target raised by analysts at HC Wainwright from $74.00 to $117.00. They now have a "buy" rating on the stock.
8/14
11:04 pm
xoma
XOMA Co. (NASDAQ: XOMA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
XOMA Co. (NASDAQ: XOMA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
8/13/2024
07:30 am
xoma
xoma royalty corporation
BEAT
Report
15.0%
xoma royalty corporation
5/9/2024
07:30 am
xoma
xoma royalty corporation
MISS
Report
-2.1%
xoma royalty corporation
11/7/2023
07:30 am
xoma
xoma royalty corporation
MISS
Report
-8.3%
xoma royalty corporation
10/22
08:16 am
xoma
Form 8-K XOMA Royalty Corp For: Oct 21
Low
Report
Form 8-K XOMA Royalty Corp For: Oct 21
9/23
06:35 am
xoma
Form 8-K XOMA Royalty Corp For: Sep 20
Low
Report
Form 8-K XOMA Royalty Corp For: Sep 20
8/13
07:46 am
xoma
Form 8-K XOMA Royalty Corp For: Aug 13
High
Report
Form 8-K XOMA Royalty Corp For: Aug 13
8/13
07:37 am
xoma
Form 10-Q XOMA Royalty Corp For: Jun 30
High
Report
Form 10-Q XOMA Royalty Corp For: Jun 30
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register